Paclitaxel in Treating Patients With Early-Stage Bladder Cancer

Phase 1/2 Completed Mary Babb Randolph Cancer Center at West Virginia University Hospitals

Treatment

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase I/II trial to study the effectiveness of paclitaxel in treating patients with early-stage bladder cancer.

Timeline

Start: 1996-11
Primary completion: —
Completion: 2004-05

Publications

Rahman KMM, Foster BA, You Y. Preclinical evaluation of singlet oxygen-cleavable prodrugs in combination with protoporphyrin IX-photodynamic therapy in an orthotopic rat model of non-muscle-invasive bladder cancer. Photochem Photobiol. 2024 Nov-Dec;100(6):1590-1602. doi: 10.1111/php.13838. Epub 2023 Jul 20.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Paclitaxel	Small molecule	—	Other

Paclitaxel in Treating Patients With Early-Stage Bladder Cancer

Summary

Timeline

Publications

Drugs

Indications